Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Learned Resourcefulness Intervention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03717077
Recruitment Status : Not yet recruiting
First Posted : October 24, 2018
Last Update Posted : November 26, 2018
Sponsor:
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Brief Summary:
This study aimed to test the effects of a learned resourcefulness interveniton program on the learned resourcefulness, caregiver burden, quality of life for older family caregivers.

Condition or disease Intervention/treatment Phase
Self-Control Caregiver Burden Quality of Life Procedure: learned resourcefulness intervention Not Applicable

Detailed Description:
A quasi-experimental trail will be used to test the effects of a learned resourcefulness intervention program on the learned resourcefulness, caregiver burden, quality of life for older family caregivers. Through the use of convenience sampling strategy, one teaching medical hospital with approximately 104 older family caregivers in southern Taiwan will be recruited and simple randomly assigned based on teaching medical hospital to a Learned resourcefulness intervention program experimental group or a wait-list control group. Participants in the experimental group will receive the learned resourcefulness intervention program led by researcher, one time per week, 50 minutes for one week, 10 minutes for these weeks; participants in the wait-list control group will continue to receive their home care service. One pre-test and two post-tests, all participants will assessed for learned resourcefulness, caregiver burden, quality of life at baseline, and at 5 and 9 weeks of the study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 104 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: Effect of Learned Resourcefulness Intervention on Learned Resourcefulness, Caregiver Burden, Quality of Life for Older Family Caregivers
Estimated Study Start Date : December 1, 2018
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : June 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Caregivers

Arm Intervention/treatment
Experimental: Learned resourcefulness intervention
The learned resourcefulness program includes: 1) Solving problem strategy, 2) Organizing daily actions, 3) Using self-regulation, 4) Reframing positive situations, 5) Changing negative self-thinking, 6) Exploring new thinking and skills. It is conducted one time per week.
Procedure: learned resourcefulness intervention
The LR program includes: 1) Solving problem strategy, 2) Organizing daily actions, 3) Using self-regulation, 4) Reframing positive situations, 5) Changing negative self-thinking, 6) Exploring new thinking and skills. It is conducted one time per week.

No Intervention: Usual home care service
The control group maintains home care service



Primary Outcome Measures :
  1. Self-control as the learned resourcefulness measured by Rosenbaum's self control schedule [ Time Frame: 9 weeks ]
    which is a 36-item scale, is used to measure the cognitive and problem-solving skills, the higher the score, the better a self-control of a person

  2. Caregiver burden measured by caregiver burden scale [ Time Frame: 9 weeks ]
    which is a 20-item scale by Lee and Wu, The total score ranges between 0 and 60, with a higher score representing a higher degree of burden.

  3. Quality of life measured by EuroQol five dimension scale (ED-5Q) [ Time Frame: 9 weeks ]
    The EuroQol five dimension scale (ED-5Q) developed by the EuroQol Group, the higher the score, the better the state of health.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • aged 60 and above
  • family caregivers of disabled adults who received home care service
  • cognitively intact as assessed by SPMSQ score of 8 and above
  • disabled adults will assessed by Barthel Index score of 60 and bellow
  • able to answer questions

Exclusion Criteria:

  • participants with severe mental disabilities

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03717077


Locations
Layout table for location information
Taiwan
Meng-Chun Chen (MCC)
Chiayi city, Taiwan, 61363
Sponsors and Collaborators
Chang Gung Memorial Hospital

Layout table for additonal information
Responsible Party: Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier: NCT03717077    
Other Study ID Numbers: 201801443B0C501
First Posted: October 24, 2018    Key Record Dates
Last Update Posted: November 26, 2018
Last Verified: October 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No